Avid Bioservices Inc (CDMO)

[JJ1223]

The information below should provide the factual basis that I used for my post. If you can find information that disproves these facts, please provide. Have a great day  
Quote:


JJ1223 Tuesday, 11/14/17 03:07:48 PM
Re: bigbro1 post# 318424
Post #
318429
of 318435 Go
Opinions are not facts nor should anyone represent them as such without clear proof.

Please provide clear proof of the following statement
JJ1223 Tuesday, 11/14/17 02:59:54 PM
Re: exwannabe post# 318421
Post #
318427
of 318435 Go
Exwannabe- to be clear, the three new BOD members were vetted by an outside agency and approved by Peregrine.

Board of Directors (from the Peregrine website)

Carlton M Johnson
Chairman
Steven W. King
President and CEO, Director
Mark R. Bamforth
Director
Roger J. Lias, Ph.D
Director
David H. Pohl
Director
Eric S. Swartz
Director
Patrick Walsh
Director
The outside search for Lias and new BOD members was clearly communicated by Peregrine.         
 
bidrite  

Tuesday, November 14, 2017 3:47:14 PM
Re: JJ1223 post# 318443

Post # of 318551 
This is only a list of the BOD, doesn't show at all where a 3rd party was used. Please provide proof of your statement.

Let me help...you won't find it. Just like partnerships brought to fruition over the coming year or profitable in 18 months or guidance of higher revenue only to be lower 4 weeks later. All lies. You have now possible way of knowing if it is true, yet post it as fact.

Quote:

Peregrine will be working with a nationally recognized executive search firm to assist in identifying highly qualified candidates for the Avid President and Board of Directors positions. The Company intends to appoint a President to the Avid business in the coming months and include the identified directors in its slate of nominees for election to the Board at its next Annual Meeting of Stockholders.
     
July 13, 2017
Peregrine Pharmaceuticals Issues Statement Regarding Ronin Trading and SW Investment Management's Letter to Stockholders


TUSTIN, Calif., July 13, 2017 (GLOBE NEWSWIRE) -- Peregrine Pharmaceuticals, Inc. (NASDAQ:PPHM) today confirmed that Ronin Trading, LLC and SW Investment Management LLC (together, "Ronin/SWIM") submitted three candidates for election to the Peregrine Board of Directors at the Company's Annual Meeting of Stockholders. The Company issued the following statement on Ronin/SWIM's nomination of directors and its letter to the Peregrine stockholders:
"Peregrine welcomes the input of our stockholders and is committed to maintaining a highly qualified Board to lead the company forward. We respect the right of stockholders to nominate directors and our Board follows a defined process to evaluate any potential nominees.

Our Nominating Committee will carefully evaluate Ronin/SWIM's nominees consistent with that process. Following the Committee's review, it will make a recommendation to the Board that is in the best interests of Peregrine and all of our stockholders.  Stockholders need take no action at this time.

It looks like all candidates will be vetted BEFORE making a recommendation to the BOD.